5 completed, 3 terminated, 1 recruiting, 1 withdrawn. 10 Phase 2.
By phase and status
Follow Lymphoseek: new trials by email Literature Review of Lymphoseek trials Research Report on Lymphoseek
Trials (filtered) newest first · largest first
All 10 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial Biospecimen Collection, Carboplatin, Cisplatin - Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8 | Phase 2 | Recruiting | 50 | 2025-07-17 | 2026-07-31 |
Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA Tc 99m tilmanocept - Rheumatoid Arthritis | Phase 2 | Terminated | 20 | 2021-09-14 | 2025-01-08 |
Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept Tc99m tilmanocept - Rheumatoid Arthritis | Phase 2 | Completed | 134 | 2021-05-27 | 2025-01-08 |
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer Lymphoseek, Single Photon Emission Computed Tomography (SPECT), Indocyanine Green (ICG) - Endometrial Cancer | Phase 2 | Terminated | 6 | 2021-01-20 | 2023-10-11 |
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer Panitumumab-IRDye800, Lymphoseek - Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 2 | Completed | 3 | 2019-08-01 | 2022-11-10 |
Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging Tc 99m tilmanocept - Rheumatoid Arthritis | Phase 2 | Completed | 116 | 2019-04-08 | 2023-08-24 |
A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus Lymphoseek - Anal Cancer | Phase 2 | Withdrawn | | 2016-09-01 | 2017-03-15 |
A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection Tc99m tilmanocept - Uterine Cervical Neoplasms | Phase 2 | Terminated | 18 | 2016-01-01 | 2019-02-11 |
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping Tc99m tilmanocept, Vital Blue Dye (optional), Lymph Node Mapping - Rhabdomyosarcoma, Melanoma | Phase 2 | Completed | 24 | 2015-08-01 | 2024-06-28 |
Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT Tc 99m tilmanocept - Kaposi's Sarcoma | Phase 2 | Completed | 5 | 2014-09-01 | 2016-09-27 |
Conditions studied
Arthritis, Rheumatoid (3) · Squamous Cell Carcinoma of Head and Neck (2) · Anus Neoplasms (1) · Disease (1) · Endometrial Neoplasms (1) · Head and Neck Neoplasms (1) · Melanoma (1) · Mouth Neoplasms (1) · Rhabdomyosarcoma (1) · Sarcoma, Kaposi (1) · Uterine Cervical Neoplasms (1)
Sponsors
Navidea Biopharmaceuticals (4) · Cardinal Health 414, LLC (3) · Eben Rosenthal (1) · Stanford University (1) · University of Michigan Rogel Cancer Center (1)
Countries
United States (9) · United Kingdom (1)
Top investigators
Michael Blue, MD (6) · Amer K Karam, MD (1) · Bonnie C Abbruzzese, MS, RD, CCRA (1) · Fred M Baik (1) · Jennifer L Shah (1)
Results publications
PMID 35958955
NIH funding
2018 (1), P30CA124435 (1), R01CA190306 (1)